Un gerente de fondos de inversión de Manhattan ha sido acusado de traficar con información confidencial sobre la aprobación de medicamentos. El caso es uno de los mayores de tráfico de información desde el 2014, cuando cambios en la ley hicieron más difícil para los fiscales perseguir estos delitos.
Featured News
Amazon Faces FTC, State Suit Over Alleged Advertising Price Manipulation
Aug 31, 2026 by
CPI
Kirkland Bolsters State AG Practice With Gibson Dunn Hire
Aug 31, 2026 by
CPI
California Antitrust Overhaul Lands on Newsom’s Desk
Aug 31, 2026 by
CPI
Baker McKenzie Hires Former New York Antitrust Enforcer
Aug 31, 2026 by
CPI
South Korea’s KFTC Clears Hanwha’s KAI Stake Purchase, Leaves Door Open to New Antitrust Review
Aug 31, 2026 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – State Attorneys General
Aug 27, 2026 by
CPI
CPI Talks… with Jonathan Skrmetti, Attorney General of Tennessee
Aug 27, 2026 by
Jonathan Skrmetti
What the Live Nation Jury Instructions Tell Us About California’s Unfair Competition Law
Aug 27, 2026 by
Henry Hauser, Brent Nakamura, Ashley Kaplan, Brian Wang & Cari Jeffries
From Backroom Deals to Public Scrutiny: The Tunney Act’s Past, Present, and Future
Aug 27, 2026 by
Christina M. Black & Ashley A. Locke
Understanding the Fragility of Economic Concentration Through the Principles of Ecology
Aug 27, 2026 by
Alexandra Spring